Multiple Myeloma and Diabetes

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...

Descripción completa

Detalles Bibliográficos
Autores principales: Issa, Zeinab A., Zantout, Mira S., Azar, Sami T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262650/
https://www.ncbi.nlm.nih.gov/pubmed/22363889
http://dx.doi.org/10.5402/2011/815013
_version_ 1782221757792387072
author Issa, Zeinab A.
Zantout, Mira S.
Azar, Sami T.
author_facet Issa, Zeinab A.
Zantout, Mira S.
Azar, Sami T.
author_sort Issa, Zeinab A.
collection PubMed
description Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.
format Online
Article
Text
id pubmed-3262650
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-32626502012-02-23 Multiple Myeloma and Diabetes Issa, Zeinab A. Zantout, Mira S. Azar, Sami T. ISRN Endocrinol Review Article Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians. International Scholarly Research Network 2011 2011-11-17 /pmc/articles/PMC3262650/ /pubmed/22363889 http://dx.doi.org/10.5402/2011/815013 Text en Copyright © 2011 Zeinab A. Issa et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Issa, Zeinab A.
Zantout, Mira S.
Azar, Sami T.
Multiple Myeloma and Diabetes
title Multiple Myeloma and Diabetes
title_full Multiple Myeloma and Diabetes
title_fullStr Multiple Myeloma and Diabetes
title_full_unstemmed Multiple Myeloma and Diabetes
title_short Multiple Myeloma and Diabetes
title_sort multiple myeloma and diabetes
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262650/
https://www.ncbi.nlm.nih.gov/pubmed/22363889
http://dx.doi.org/10.5402/2011/815013
work_keys_str_mv AT issazeinaba multiplemyelomaanddiabetes
AT zantoutmiras multiplemyelomaanddiabetes
AT azarsamit multiplemyelomaanddiabetes

Ejemplares similares